Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proteostasis Deficiencies”

1,774 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,774 results

Testing effectiveness (Phase 2)Study completedNCT00036413
What this trial is testing

A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Novartis Pharmaceuticals 44
Early research (Phase 1)Active Not RecruitingNCT03283917
What this trial is testing

Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis

Who this might be right for
Newly Diagnosed Primary AmyloidosisRecurrent Primary AmyloidosisRefractory Primary Amyloidosis
M.D. Anderson Cancer Center 21
Not applicableWithdrawnNCT05497817
What this trial is testing

Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia

Who this might be right for
Caregiver StressDementiaAlzheimer Dementia+3 more
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT02590588
What this trial is testing

Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis

Who this might be right for
Amyloidosis
John Mark Sloan 1
Not applicableStudy completedNCT03613038
What this trial is testing

A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive Dysarthria

Who this might be right for
Amyotrophic Lateral SclerosisParkinson Disease
University of Missouri-Columbia 100
Testing effectiveness (Phase 2)UnknownNCT04318626
What this trial is testing

The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment

Who this might be right for
Post-stroke Cognitive ImpairmentNeuroinflammation
Chang Gung Memorial Hospital 80
Early research (Phase 1)Looking for participantsNCT05652335
What this trial is testing

JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Who this might be right for
Relapsed or Refractory Multiple MyelomaPreviously Treated Amyloid Light-chain (AL) Amyloidosis
Janssen Research & Development, LLC 180
Testing effectiveness (Phase 2)Study completedNCT00005674
What this trial is testing

Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]

Who this might be right for
Amyotrophic Lateral Sclerosis
National Center for Research Resources (NCRR)
Testing effectiveness (Phase 2)Study completedNCT02676843
What this trial is testing

Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations

Who this might be right for
Frontotemporal Lobar Degeneration (FTLD)Frontotemporal Dementia (FTD)Tauopathies
Columbia University 7
Testing effectiveness (Phase 2)Ended earlyNCT05053035
What this trial is testing

Evaluate AL001 in C9orf72-Associated ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Alector Inc. 5
Not applicableStudy completedNCT00024908
What this trial is testing

Test of A Model of Representational Knowledge Stored in the Human Prefrontal Cortex

Who this might be right for
Intracranial Central Nervous System DisorderMental DisorderHealthy
National Institute of Neurological Disorders and Stroke (NINDS) 949
Not applicableAvailableNCT07088159
What this trial is testing

Intermediate-size Patient Population Expanded Access Protocol

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Spinogenix
Large-scale testing (Phase 3)Study completedNCT01994889
What this trial is testing

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Who this might be right for
Transthyretin (TTR) Amyloid Cardiomyopathy
Pfizer 441
Not applicableUnknownNCT05701397
What this trial is testing

Prevalence of Cardiac Amyloidosis in Patients Undergoing Surgery for Lumbar Spinal Stenosis.

Who this might be right for
Cardiac AmyloidosisSpinal Stenosis
Steen Hvitfeldt Poulsen 200
Early research (Phase 1)UnknownNCT00574054
What this trial is testing

Far Infrared Radiation Treatment of Dementia and Other Mental Illness

Who this might be right for
Dementia
GAAD Medical Research Institute Inc. 4
Not applicableStudy completedNCT03030586
What this trial is testing

ADDIA Proof-of-Performance Clinical Study

Who this might be right for
Alzheimer Disease (AD)Frontotemporal Lobar DegenerationDementia with Lewy Bodies (DLB)+3 more
Amoneta Diagnostics SAS 821
Not applicableUnknownNCT04089696
What this trial is testing

Validation of the "ExSpiron©" in Patients With ALS

Who this might be right for
Amyotrophic Lateral SclerosisNeuromuscular Diseases
University Medical Center Groningen 10
Not applicableEnded earlyNCT00718445
What this trial is testing

Pennsylvania Consortium: Clinical Database

Who this might be right for
Amyotrophic Lateral SclerosisNeurodegenerative DiseaseMotor Neuron Disease
Drexel University College of Medicine 25
Not applicableLooking for participantsNCT06539169
What this trial is testing

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Who this might be right for
Alpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more
xCures 1,000
Early research (Phase 1)Study completedNCT01142856
What this trial is testing

Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Mayo Clinic 1
Load More Results